7 results
Recommended Therapeutic Approach to the Patient with Hypertrophic Cardiomyopathy (HOCM)
ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blockers;
the Patient with Hypertrophic ... Cardiomyopathy (HOCM ... #HOCM #HcM #Hypertrophic ... Cardiomyopathy #Algorithm ... #Management #Cardiology
Etiologies of hypertrophic cardiomyopathy
 - Genetic 
 - Storage diseases 
 - Neuromuscular and mitochondrial disorders
Etiologies of hypertrophic ... mitochondrial disorders ... esctwitter #HOCM ... differential #diagnosis #cardiology ... #causes
Hypertrophic Cardiomyopathy (HOCM) - Diagnosis and Management
Diagnosis
 1. Wall thickness 215 mm (TTE/CT/MRI) 
 2. Absence
Hypertrophic Cardiomyopathy ... (HOCM) - Diagnosis ... and Management ... Absence of Secondary Cause ... #Cardiology
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
left ventricular hypertrophy ... Staging #Stages #ACCAHA ... #Algorithm #Management ... #Cardiology
WOBBLER  for ECG assessment in Syncope 
W - Wolff Parkinson White 
O - Obstructed AV
(consider AS, HOCM ... syncope, can be caused ... characteristically cause ... cardiomyopathy, a rare disorder ... ECG #Diagnosis #Cardiology
STAGES of CHF (A, B, C, D), however, describe the severity of structural abnormalities that impair
flare ups that cause ... #Management #Cardiology ... Staging #Stages #ACCAHA ... #Algorithm
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
Most cases are related ... hemoproliferative disorder ... • Treatment algorithms ... #diagnosis #management ... #hematology